Key result
Random forest model strongly predicts ACS neurocognitive function, identifying HDL, depression, and glucose as top predictors.
Why the study?
The interplay between coronary disease and neurocognitive dysfunction remains unclear with several underlying factors likely contributing to this complex relationship.
Cross-Sectional (n=63)
No
Effect estimate: R-squared 0.978
A machine learning model utilizing classical cardiovascular risk factors, biochemical indicators, and depression scores can accurately predict neurocognitive functioning in post-ACS patients.
May aid neurocognitive risk stratification in ACS; leaves open prospective validation before clinical adoption.
Introduction: The interplay between coronary disease and neurocognitive dysfunction remains unclear with several underlying factors likely contributing to this complex relationship. This study develops a predictive model using a machine learning approach to determine a predictive model of neurocognitive functioning in patients with acute coronary syndrome (ACS). Methods: Sixty-three patients, enrolled in the phase III cardiac rehabilitation program, underwent a neurocognitive assessment. To predict neurocognitive functioning a cross validated random forest model was used (RF_cv) due to its robustness to non-linear relationships and overfitting, and its successful application in prior disease prediction studies. Results: The RF_cv model showed an r-squared of 0.978, an RMSE of 0.6309 and a MAE value of 0.479. The top-ten predictors in the model were: HDL, Depression, Glucose, Glycated Hemoglobin, B-Type Natriuretic Peptide, BMI (Kg/m2), Waist-to-Hip Ratio, Cholesterol, Anxiety and Age. Conclusion: The variance in neurocognitive functioning is explained by a combination of biochemical indicators and body composition, reflecting classical cardiovascular risk factors and depression. The obtained RF-cv predictive model supports early identification of patients for tailored interventions.
No takes yet. Share an insight, caveat, or question.
Moreira et al. (2025) conducted a cross-sectional in Acute Coronary Syndrome (n=63). Clinical, biochemical, and psycho-emotional risk factors was evaluated on Neurocognitive functioning (ACE-III z-score) (R-squared 0.978). A cross-validated random forest model strongly predicted neurocognitive functioning in patients with acute coronary syndrome (R-squared 0.978), identifying HDL, depression, and glucose as the top predictors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: